ClearPoint Neuro, Inc.
CLPT
$17.86
-$0.12-0.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 42.93% | 33.96% | 9.10% | 17.27% | 11.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.93% | 33.96% | 9.10% | 17.27% | 11.07% |
| Cost of Revenue | 30.39% | 33.13% | -0.43% | 27.49% | 7.68% |
| Gross Profit | 51.13% | 34.48% | 15.54% | 11.39% | 13.41% |
| SG&A Expenses | 47.95% | 19.05% | 10.97% | 12.36% | 29.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.67% | 16.77% | 6.45% | 18.38% | 23.56% |
| Operating Income | -37.56% | 6.94% | -2.29% | -20.24% | -46.18% |
| Income Before Tax | -58.85% | -43.63% | -18.61% | -32.30% | -45.44% |
| Income Tax Expenses | -55.56% | 112.50% | -42.86% | 66.67% | 20.00% |
| Earnings from Continuing Operations | -58.51% | -44.56% | -18.44% | -32.42% | -45.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.51% | -44.56% | -18.44% | -32.42% | -45.34% |
| EBIT | -37.56% | 6.94% | -2.29% | -20.24% | -46.18% |
| EBITDA | -35.07% | 8.69% | -6.46% | -17.66% | -52.53% |
| EPS Basic | -48.71% | -38.27% | -14.92% | -28.72% | -33.46% |
| Normalized Basic EPS | -49.00% | -5.62% | -15.04% | -28.50% | -33.63% |
| EPS Diluted | -48.71% | -38.27% | -14.92% | -28.72% | -33.46% |
| Normalized Diluted EPS | -49.00% | -5.62% | -15.04% | -28.50% | -33.63% |
| Average Basic Shares Outstanding | 6.59% | 4.56% | 3.03% | 2.88% | 8.91% |
| Average Diluted Shares Outstanding | 6.59% | 4.56% | 3.03% | 2.88% | 8.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |